Group-based [ADAPT] Versus One-to-one [Usual] Occupational Therapy (Go:OT Trial)

NCT06058754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2023-09-28

No results posted yet for this study

Summary

This trial aims to evaluate the ADAPT Program in terms of efficacy, process and cost-efficacy compared to usual occupational therapy (UOT) in people with decreased ability to perform activities of daily living (ADL) following chronic conditions. As both the ADAPT Program and UOT are targeted improvements in ADL ability, the primary objective of this trial is to assess equivalence between the ADAPT Program and UOT on changes in ADL ability as measured with the Assessment of Motor and Process Skills (AMPS).

Conditions

Interventions

BEHAVIORAL

The ADAPT Program

The ADAPT Program is a structured and individualized 10-week group-based program, in which two occupational therapists teach groups of people, the skills of problem-solving more efficiently as means to overcome ADL task performance problems. The ADAPT Program 3.0 includes 2 individual two-hour sessions (sessions 1 and 10) conducted in the clients homes and eight two-hour group-based sessions (sessions 2-9). Moreover, two booster sessions (sessions 11 and 12) are delivered to support sustainable gains after termination of the 10-week ADAPT Program 3.0

BEHAVIORAL

UOT

UOT is delivered by one occupational therapist. Sessions are individualised and focused on improving ADL ability e.g. by practicing the performance of ADL task or adjusting home environments. UOT typically includes 7 one-to-one sessions of 60 minutes, delivered over a 10-week period in the clients´ homes. The dose is however not fixed but based on the occupational therapists´ clinical judgement in collaboration with the individual client

Sponsors & Collaborators

  • Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre Kommune)

    collaborator UNKNOWN
  • Den Kommunale Kvalitetsudviklingspulje

    collaborator UNKNOWN
  • Lundbeckpuljen

    collaborator UNKNOWN
  • Oak Foundation

    collaborator OTHER
  • Tværspuljen

    collaborator UNKNOWN
  • Parker Research Institute

    lead OTHER

Principal Investigators

  • Cecilie von Bülow, PhD · Parker Institute, Bispebjerg and Frederiksberg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-04
Primary Completion
2024-09-27
Completion
2024-12-06

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06058754 on ClinicalTrials.gov